DOAC-Remove™50 | Auxiliary Reagents - Other Auxiliary Reagents

Description

DOAC-Remove^TM tablets are intended to be used for removal of direct oral anticoagulant (DOAC) compounds from human citrated plasma samples, including dabigatran, rivaroxaban, apixaban and edoxaban. Also removes argatroban. DOAC-Remove^TM has no significant effect on clotting factors.

Intended use

Removes DOACs and argatroban from citrated plasmas thereby reducing interference when the plasma is tested in laboratory coagulation assays such as aPTT, TT, single factors, lupus AC, and APC-R.

Name	Purpose	Lifetime	Type	Provider
CookieConsent	missing translation: trackingobject.CookieConsent.desc	1 missing translation: duration.year	missing translation: type.cookie_http+html	Website
fe_typo_user	missing translation: trackingobject.fe_typo_user.desc	missing translation: duration.session	missing translation: type.cookie_http	Website

Name	Purpose	Lifetime	Type	Provider
_pk_id	missing translation: trackingobject._pk_id.desc	13 missing translation: duration.months	missing translation: type.cookie_http+html	Matomo
_pk_ref	missing translation: trackingobject._pk_ref.desc	6 missing translation: duration.months	missing translation: type.cookie_http+html	Matomo
_pk_ses	missing translation: trackingobject._pk_ses.desc	30 missing translation: duration.minutes	missing translation: type.cookie_http+html	Matomo
_pk_cvar	missing translation: trackingobject._pk_cvar.desc	30 missing translation: duration.minutes	missing translation: type.cookie_http+html	Matomo
_pk_hsr	missing translation: trackingobject._pk_hsr.desc	30 missing translation: duration.minutes	missing translation: type.cookie_http+html	Matomo

Your Coagulation Experts

DOAC-Remove^™50

Description

Intended use

Related Products